An advocate general has advised the Court of Justice of the European Union (CJEU) on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
17 September 2019 The Court of Justice of the European Union last week issued its decision in a case concerning whether a ‘launch at risk’ bars compensation for a wrongfully issued preliminary injunction.
6 February 2019 A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
17 September 2019 The Court of Justice of the European Union last week issued its decision in a case concerning whether a ‘launch at risk’ bars compensation for a wrongfully issued preliminary injunction.
6 February 2019 A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
17 September 2019 The Court of Justice of the European Union last week issued its decision in a case concerning whether a ‘launch at risk’ bars compensation for a wrongfully issued preliminary injunction.
6 February 2019 A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
